Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Evomed AB
AB
Active
Org 5569504227
Vasserudsvägen 11, 685 34
Torsby
Physiotherapy activities
·
NACE 8695
Est. 2013 · 12 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Physiotherapy activities
/
Evomed AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
4M
3M
2M
1M
0M
2021: 3M
3M
2021
2022: 2M (-33% vs 2021)
2M
-33%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 2M (0% vs 2023)
2M
0%
2024
2025: 2M (0% vs 2024)
2M
0%
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
2 202
2 134
1 982
2 178
2 642
Staff expenses
−718
−589
−793
−1 196
—
EBITDA
−166
140
161
−34
227
Depreciation & amort.
−34
−28
−28
−28
−53
EBIT
−200
112
133
−62
174
Net financials
0
4
1
−8
−19
Profit before tax
−200
116
134
−29
115
Tax
—
−26
−25
—
−25
Net profit
−200
90
109
−29
90
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
336
505
535
472
744
Equity
161
361
421
311
341
Long-term debt
—
—
—
0
82
Short-term debt
175
144
115
161
280
Total debt
175
144
115
161
362
Financial ratios
5-year trend
EBITDA margin
−7,5 %
This company
15,8 %
Market median
This company
Market median
147% below market
2021
2025
Equity ratio
48,0 %
This company
38,2 %
Market median
This company
Market median
26% above market
2021
2025
Return on equity
−123,8 %
This company
18,4 %
Market median
This company
Market median
773% below market
2021
2025
Net profit margin
−9,1 %
This company
8,1 %
Market median
This company
Market median
212% below market
2021
2025
Asset turnover
6,56×
This company
1,12×
Market median
This company
Market median
486% above market
2021
2025
Debt / equity
1,08×
This company
0,62×
Market median
This company
Market median
74% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Evomed AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
